Juravinski Research Institute

Skip to content

Home
About the Institute
Research Projects
In the News
Publications
Donate

Home

Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms

Second dose of AstraZeneca COVID-19 vaccine: FAQs about blood clots, safety, risks and symptoms

Posted on May 31, 2021

Twitter Facebook LinkedIn

Read more at The Conversation.

In the News

Juravinski Research Institute

Twitter

Contact Us

JRIsec@mcmaster.ca

#JuravinskiLegacy

Partner Organizations

Hamilton Health Sciences

McMaster University

St. Joseph’s Healthcare Hamilton

Media Production Services is committed to providing websites that are accessible to the widest possible audience.
If there is a technical accessibility issue with this website, please report it to us by using our accessibility bug report form.

This website is powered by MacSites